A new study has found that verapamil - used to treat high blood pressure, irregular heartbeat and migraine - can lower fasting glucose levels in diabetes patients.
The Food and Drug Administration (FDA) has reported that the Namenda XR (memantine HCl) extended-release capsules shortage has been resolved as of February 11, 2016.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection
For patients with type 1 diabetes, fat quality influences postprandial blood glucose (PPG) response in the context of meals with high-glycemic index (HGI), according to a study published online in Diabetes Care.
Dexamethasone doesn't reduce mortality; linked to higher percentage of patients with disability
Only one-in-five with heart failure with reduced ejection fraction receive digoxin at discharge
Functional magnetic resonance imaging with central sensitization can be used in early human drug development, according to a study published in the January issue of Anesthesiology.
High-dose intravenous sedatives not associated with excess morbidity or mortality
The rate of missed adenomas larger than 5 mm is similarly low for men with Boston Bowel Prep Scale (BBPS) scores of 2 or 3, according to a study published in the February issue of Gastroenterology.
The rate of smoking during pregnancy is about 8.4%, with greater prevalence among women aged 20 to 24 years, according to a report published by the National Center for Health Statistics.
- Researchers Get Closer to Testing Anti-Aging Pill in Humans
- Verapamil May Help Lower Glucose Levels in Diabetic Patients
- Alzheimer's Drug Shortage Resolved
- Recommendations for Management of Recurrent UTI in Older Men
- Impacts of Low/High Glycemic Foods to Postprandial Blood Glucose in Type 1 Diabetes